FDA Inspection 701336 — Nanjing Maohai Biotech Co.
The FDA completed an inspection of Nanjing Maohai Biotech Co. on October 28, 2010 in Nanjing. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- October 28, 2010
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Nanjing (China)